RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Idhaliz Flores to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Idhaliz Flores has written about Treatment Outcome.
Idhaliz Flores
Connection Strength
0.031
Treatment Outcome
  1. Torres-Rever?n A, Rivera-Lopez LL, Flores I, Appleyard CB. Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis. PLoS One. 2018; 13(11):e0197698.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support